Literature DB >> 35621171

Male and female rats exhibit comparable gaping behavior but activate brain regions differently during expression of conditioned nausea.

Alyssa Bernanke1, Samantha Sette, Nathaniel Hernandez, Sara Zimmerman, Justine Murphy, Reynold Francis, Zackery Reavis, Cynthia Kuhn.   

Abstract

Twenty-five to fifty percent of patients undergoing chemotherapy will develop anticipatory nausea and vomiting (ANV), in which symptoms occur in anticipation of treatment. ANV is triggered by environmental cues and shows little response to traditional antiemetic therapy, suggesting that unique neural pathways mediate this response. Understanding the underlying neural mechanisms of this disorder is critical to the development of novel therapeutic interventions. The purpose of the present study was to identify brain areas activated during ANV and characterize sex differences in both the behavior and the brain areas activated during ANV. We used a rat model of ANV by pairing a novel context with the emetic drug lithium chloride (LiCl) to produce conditioned nausea behaviors in the LiCl-paired environment. We quantitated gaping, an analog of human vomiting, after acute or repeated LiCl in a unique environment. To identify brain regions associated with gaping, we measured c-fos activation by immunochemical staining after these same treatments. We found that acute LiCl activated multiple brain regions including the supraoptic nucleus of the hypothalamus, central nucleus of the amygdala, nucleus of the solitary tract and area postrema, none of which were activated during ANV. ANV activated c-fos expression in the frontal cortex, insula and paraventricular nucleus of the hypothalamus of males but not females. These data suggest that therapies such as ondansetron which target the area postrema are not effective in ANV because it is not activated during the ANV response. Further studies aimed at characterizing the neural circuits and cell types that are activated in the conditioned nausea response will help identify novel therapeutic targets for the treatment of this condition, improving both quality of life and outcomes for patients undergoing chemotherapy.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35621171      PMCID: PMC9354039          DOI: 10.1097/FBP.0000000000000676

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.277


  77 in total

Review 1.  The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis.

Authors:  M A Andrykowski
Journal:  Psychosom Med       Date:  1990 Jul-Aug       Impact factor: 4.312

2.  Disgust and the insula: fMRI responses to pictures of mutilation and contamination.

Authors:  P Wright; G He; N A Shapira; W K Goodman; Y Liu
Journal:  Neuroreport       Date:  2004-10-25       Impact factor: 1.837

Review 3.  Regulation of nausea and vomiting by cannabinoids.

Authors:  Linda A Parker; Erin M Rock; Cheryl L Limebeer
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  Simultaneous conditioning of "gaping" responses and taste avoidance in rats injected with LiCl and saccharin: examining the role of context and taste cues in the rodent model of anticipatory nausea.

Authors:  Caylen J Cloutier; Shelley K Cross-Mellor; Martin Kavaliers; Klaus-Peter Ossenkopp
Journal:  Neurosci Lett       Date:  2011-07-14       Impact factor: 3.046

5.  C-fos expression in the rat brain after intraperitoneal injection of lithium chloride.

Authors:  T Yamamoto; T Shimura; N Sako; S Azuma; W Z Bai; S Wakisaka
Journal:  Neuroreport       Date:  1992-12       Impact factor: 1.837

6.  Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.

Authors:  D Bolognini; E M Rock; N L Cluny; M G Cascio; C L Limebeer; M Duncan; C G Stott; F A Javid; L A Parker; R G Pertwee
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 7.  Mechanisms by which cancer chemotherapeutic drugs induce emesis.

Authors:  L X Cubeddu
Journal:  Semin Oncol       Date:  1992-12       Impact factor: 4.929

8.  c-Fos induction in response to taste stimuli previously paired with amphetamine or LiCl during taste aversion learning.

Authors:  M W Swank; G E Schafe; I L Bernstein
Journal:  Brain Res       Date:  1995-03-06       Impact factor: 3.252

9.  Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Hironobu Hashimoto; Masakazu Abe; Osamu Tokuyama; Hideaki Mizutani; Yosuke Uchitomi; Takuhiro Yamaguchi; Yukari Hoshina; Yasuhiko Sakata; Takako Yanai Takahashi; Kazuhisa Nakashima; Masahiko Nakao; Daisuke Takei; Sadamoto Zenda; Koki Mizukami; Satoru Iwasa; Michiru Sakurai; Noboru Yamamoto; Yuichiro Ohe
Journal:  Lancet Oncol       Date:  2019-12-11       Impact factor: 41.316

10.  Anticipatory nausea and emesis, and psychological morbidity: assessment of prevalence among out-patients on mild to moderate chemotherapy regimens.

Authors:  M Watson; J McCarron; M Law
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.